MedPAC Considers Reference Pricing and Other Ideas for Cutting Part B Drug Costs
Congress will need to use a multipronged approach to bring down prescription drug costs in the Medicare Part B program, members of the Medicare Payment Advisory Commission (MedPAC) agreed at their March meeting on Thursday. MedPAC members discussed three draft recommendations being considered for inclusion in the commission’s June report to Congress. The recommendations addressed […]